Patents by Inventor Julius Rebek
Julius Rebek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100113466Abstract: There are provided alpha helix scaffolds mimicking i, i+3/i+4, i+7 or i+11 residues having the general structure oxazole-pyridazine-piperidine or oxazole-pyridazine-oxazole. The common pyridazine heterocycle originates from substituted or unsubstituted dimethyl 1,2,4,5-tetrazine-3,6-dicarboxylate. These scaffolds are synthetic counterparts of amphiphilic alpha helices having a hydrophilic face along one side and a hydrophobic face along the other side of the helix.Type: ApplicationFiled: October 8, 2009Publication date: May 6, 2010Applicants: Office of Patent CounselInventors: Julius Rebek, JR., Lionel Moisan
-
Publication number: 20100022549Abstract: The synthesis of new ?-helix scaffolds mimicking i, i+3 or i+4, i+7 residues, was accomplished. The common pyridazine heterocycle originates from the easily available dimethyl pyridazine-3,6-dicarboxylate building block. These scaffolds may be thought of as synthetic counterparts of amphiphilic ?-helices having a hydrophilic face along one side and a hydrophobic face along the other side of the helix.Type: ApplicationFiled: July 23, 2009Publication date: January 28, 2010Applicant: The Scripps Research InstituteInventors: Julius Rebek, JR., Lionel Moisan, Alexandre Carella, Enrique Mann
-
Publication number: 20090298835Abstract: Functionalized pyridazine derivatives having a low molecular weight and pharmaceutical compositions thereof are useful as alpha-helix mimetics and for treating conditions and/or disorders mediated by alpha-helix-binding receptors and proteins.Type: ApplicationFiled: July 15, 2009Publication date: December 3, 2009Applicant: The Scripps Research InstituteInventors: Julius Rebek, JR., Shen Gu, Shannon Biros
-
Patent number: 7579350Abstract: Functionalized pyridazine derivatives having a low molecular weight and pharmaceutical compositions thereof are useful as alpha-helix mimetics and for treating conditions and/or disorders mediated by alpha-helix-binding receptors and proteins.Type: GrantFiled: March 3, 2006Date of Patent: August 25, 2009Assignee: The Scripps Research InstituteInventors: Julius Rebek, Jr., Shen Gu, Shannon Biros
-
Publication number: 20090197895Abstract: Amphiphilic ?-helix mimetics are provided. These compounds are constructed using an oxazole-pyrrole-piperazine (OPP) scaffold. The amphiphilic ?-helix mimetics are also employable for making libraries and for treating diseases or conditions effected by the inhibition or disruption of interactions with the alpha helix of a protein.Type: ApplicationFiled: January 30, 2009Publication date: August 6, 2009Applicant: The Scripps Research InstituteInventors: Julius Rebek, JR., Shannon Biros, Lionel Moisan, Severin Odermatt
-
Publication number: 20090069334Abstract: The synthesis of new ?-helix scaffolds mimicking i, i+3 or i+4, i+7 residues, was accomplished. The common pyridazine heterocycle originates from the easily available building block, 6. These scaffolds may be thought of as synthetic counterparts of amphiphilic ?-helices having a “wet face” along one side and a hydrophobic face along the other side of the helix.Type: ApplicationFiled: August 13, 2008Publication date: March 12, 2009Applicant: The Scripps Research InstituteInventors: Julius Rebek, JR., Shannon Biros, Lionel Moisan, Alessandro Volonterio, Enrique Mann, Trevor Dale
-
Patent number: 7126006Abstract: The present invention provides novel glycoluril derivatives for use as core molecules in combinatorial chemistry. Core molecules of the present invention can contain from one to six building blocks. Preferred building blocks are substituted amine radicals. Combinatorial libraries containing such core molecules are also provided.Type: GrantFiled: May 19, 2005Date of Patent: October 24, 2006Assignee: The Scripps Research InstituteInventors: Julius Rebek, Jr., Kent E. Pryor
-
Publication number: 20060205728Abstract: Functionalized pyridazine derivatives having a low molecular weight and pharmaceutical compositions thereof are useful as alpha-helix mimetics and for treating conditions and/or disorders mediated by alpha-helix-binding receptors and proteins.Type: ApplicationFiled: March 3, 2006Publication date: September 14, 2006Applicant: The Scripps Research InstituteInventors: Julius Rebek, Shen Gu, Shannon Biros
-
Publication number: 20050250830Abstract: The present invention provides novel glycoluril derivatives for use as core molecules in combinatorial chemistry. Core molecules of the present invention can contain from one to six building blocks. Preferred building blocks are substituted amine radicals. Combinatorial libraries containing such core molecules are also provided.Type: ApplicationFiled: May 19, 2005Publication date: November 10, 2005Applicant: The Scripps Research InstituteInventors: Julius Rebek, Kent Pryor
-
Patent number: 6939973Abstract: The present invention provides novel glycoluril derivatives for use as core molecules in combinatorial chemistry. Core molecules of the present invention can contain from one to six building blocks. Preferred building blocks are substituted amine radicals. Combinatorial libraries containing such core molecules are also provided.Type: GrantFiled: February 9, 1999Date of Patent: September 6, 2005Assignee: The Scripps Research InstituteInventors: Julius Rebek, Jr., Kent E. Pryor
-
Publication number: 20050037435Abstract: Methods for the generation of new compounds are disclosed. The present invention eliminates the need to know in advance the structure or chemical composition of a compound having a desired property. The disclosure of the present invention provides that diversity of unknown compounds may be produced by “random” chemistry, and such a diversity of unknown compounds may be screened for one or more desired properties to detect the presence of suitable compounds. In one aspect, a starting group of organic compounds is caused to undergo a series of chemical reactions to create a diversity of new organic compounds that are screened for the presence of organic compounds having the desired property. In another aspect of the present invention, a diversity of compounds is generated from a group of substrates which are subjected to a group of enzymes representing a diversity of catalytic activities.Type: ApplicationFiled: September 2, 2004Publication date: February 17, 2005Inventors: Stuart Kauffman, Julius Rebek
-
Publication number: 20020115092Abstract: Mechanically linked energy transfer labels comprising at least one donor fluorophore, at least one acceptor fluorophore, and at least one support member, wherein steric interactions between the donor fluorophore(s), the acceptor fluorophore(s), and/or the support member(s) induce non-covalent association between the fluorophores and the support member(s), thereby forming a three-dimensional macromolecular structure which mechanically links the donor fluorophore(s) and the acceptor fluorophore(s). Fluorescence resonance energy transfer (FRET) occurs from donor fluorophore to acceptor fluorophore through space. No direct connectivity with covalent bonds exists between the fluorophores. Instead, mechanical barriers hold the donor/acceptor fluorophores in place during the FRET process.Type: ApplicationFiled: November 8, 2001Publication date: August 22, 2002Applicant: The Scripps Research InstituteInventor: Julius Rebek
-
Patent number: 5877030Abstract: Methods for forming combinatorial libraries and the libraries produced thereby are provided. According to a preferred aspect of the invention, a plurality of core molecules are reacted with a plurality of different tool molecules to form a library of molecules having non-naturally occurring molecular diversity. The libraries are useful for identifying lead compounds which modulate the functional activity of a biological molecule. Protease inhibitors that have been isolated from the libraries also are disclosed.Type: GrantFiled: May 31, 1995Date of Patent: March 2, 1999Inventors: Julius Rebek, Jr., Thomas Carell, Edward A. Wintner
-
Patent number: 5726195Abstract: Certain novel aminoacyl adenylate mimics are described. An exemplary compound of this invention is ?S-(R*,R*)!-3,6-anhydro-1,2-dideoxy-1-?5-?4-?(5-nitro-2-thienyl)ethynyl!ph enyl!-2H-tetrazol-2-yl!-D-allo-heptitol 7-(2-amino-3-methyl-1-oxopentyl)sulfamate. These compounds inhibit isoleucyl-tRNA synthetases and are useful as antimicrobial and antiparasitic agents.Type: GrantFiled: July 16, 1996Date of Patent: March 10, 1998Assignee: Cubist Pharmaceuticals, Inc.Inventors: Jason M. Hill, Guixue Yu, Youe-Kong Shue, Thomas M. Zydowsky, Julius Rebek
-
Patent number: 4861564Abstract: The compounds of the invention comprise the condensation product, as well as derivatives thereof, of two equivalents of a trimethyl cyclohexane-anhydride acid chloride derivative with one equivalent of an aromatic diamine. The scope of the invention includes the method of using the compounds of the invention as chelating agents for metals, metal ions or ions of metal complexes. In a preferred embodiment of the invention the binding moieties of the cyclohexane derivatives are rigidly held opposite each other, by restricting their rotation about the N-C aryl bonds, in order to more effectively bind the metals or the ions.Type: GrantFiled: October 2, 1987Date of Patent: August 29, 1989Assignee: Year Laboratories, Inc.Inventor: Julius Rebek
-
Patent number: 4698425Abstract: The compounds of the invention comprise the condensation product, as well as derivatives thereof, of two equivalents of a trimethyl cyclohexane-anhydride acid chloride derivative with one equivalent of an aromatic diamine. The scope of the invention includes the method of using the compounds of the invention as chelating agents for metals, metal ions or ions of metal complexes. In a preferred embodiment of the invention the binding moieties of the cyclohexane derivatives are rigidly held opposite each other, by restricting their rotation about the N-C aryl bonds, in order to more effectively bind the metals or the ions.Type: GrantFiled: July 24, 1984Date of Patent: October 6, 1987Assignee: Year Laboratories, Inc.Inventor: Julius Rebek